| Literature DB >> 33589454 |
Daisuke Yoneoka1,2,3, Shoi Shi4,5, Shuhei Nomura1,3, Yuta Tanoue6, Takayuki Kawashima7, Akifumi Eguchi8, Kentaro Matsuura9,10, Koji Makiyama10,11, Shinya Uryu12, Keisuke Ejima13, Haruka Sakamoto1,3, Toshibumi Taniguchi14, Hiroyuki Kunishima15, Stuart Gilmour2, Hiroshi Nishiura16, Hiroaki Miyata17.
Abstract
OBJECTIVE: On 7 April 2020, the Japanese government declared a state of emergency in response to the novel coronavirus outbreak. To estimate the impact of the declaration on regional cities with low numbers of COVID-19 cases, large-scale surveillance to capture the current epidemiological situation of COVID-19 was urgently conducted in this study.Entities:
Keywords: COVID-19; epidemiology; health policy; infectious diseases
Year: 2021 PMID: 33589454 PMCID: PMC7886666 DOI: 10.1136/bmjopen-2020-042002
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Map of five prefectures: Tottori, Kagawa, Shimane, Tokushima and Okayama.
Demographic characteristics of participants by health conditions during the study period for the five prefectures combined
| Total, N=127 121 | |||||
| No symptom (n=124 319, 97.80%) | (A) Fever ≥37.5°C (n=1146, 0.90%) | (B) Strong feeling of weariness or shortness of breath (n=2145, 1.69%) | Both (A) and (B) (n=489, 0.38%) | Either (A) or (B) (n=2802, 2.20%) | |
| Age, years | |||||
| Mean (SD) | 43.17 (12.7) | 38.04 (14.1) | 37.5 (12.37) | 39.08 (15.3) | 37.44 (12.54) |
| Range (minimum–maximum) | 15–101 | 15–101 | 15–101 | 15–101 | 15–101 |
| 13–19 | 3279 (2.64) | 72 (6.28) | 104 (4.85) | 30 (6.13) | 146 (5.21) |
| 20–29 | 14 293 (11.50) | 242 (21.12) | 486 (22.66) | 104 (21.27) | 624 (22.27) |
| 30–39 | 31 287 (25.17) | 382 (33.33) | 706 (32.91) | 149 (30.47) | 939 (33.51) |
| 40–49 | 37 550 (30.2) | 234 (20.42) | 513 (23.92) | 103 (21.06) | 644 (22.98) |
| 50–59 | 24 753 (19.91) | 120 (10.47) | 231 (10.77) | 51 (10.43) | 300 (10.71) |
| 60–69 | 10 305 (8.29) | 53 (4.62) | 70 (3.26) | 26 (5.32) | 97 (3.46) |
| 70–79 | 2557 (2.06) | 31 (2.71) | 21 (0.98) | 14 (2.86) | 38 (1.36) |
| 80–89 | 281 (0.23) | 12 (1.05) | 14 (0.65) | 12 (2.45) | 13 (0.46) |
| ≥90 | 14 (0.01) | Combined* | Combined* | Combined* | Combined* |
| Sex | |||||
| Female | 78 655 (63.27) | 672 (58.64) | 1291 (60.19) | 262 (53.58) | 1701 (60.71) |
| Male | 45 664 (36.73) | 474 (41.36) | 854 (39.81) | 227 (46.42) | 1101 (39.29) |
| Pregnant | 1624 (1.31) | 19 (1.66) | 46 (2.14) | 9 (1.84) | 56 (2.00) |
| Occupation | |||||
| Self-employed | 11 810 (9.5) | 111 (9.69) | 216 (10.07) | 52 (10.63) | 275 (9.81) |
| Employees | 50 897 (40.94) | 436 (38.05) | 806 (37.58) | 169 (34.56) | 1073 (38.29) |
| Public officials | 12 287 (9.88) | 91 (7.94) | 162 (7.55) | 43 (8.79) | 210 (7.49) |
| Student | 4967 (4.00) | 96 (8.38) | 138 (6.43) | 39 (7.98) | 195 (6.96) |
| Part–time workers | 17 362 (13.97) | 154 (13.44) | 303 (14.13) | 48 (9.82) | 409 (14.6) |
| Unemployed | 13 626 (10.96) | 133 (11.61) | 287 (13.38) | 76 (15.54) | 344 (12.28) |
| Others | 13 370 (10.75) | 125 (10.91) | 233 (10.86) | 62 (12.68) | 296 (10.56) |
| Taking antifebrile medications (Loxonin, Calonal and so on) | |||||
| Current | 1628 (1.31) | 445 (38.83) | 578 (26.95) | 219 (44.79) | 804 (28.69) |
| Past 1 month | 4820 (3.88) | 169 (14.75) | 432 (20.14) | 90 (18.4) | 511 (18.24) |
| Diseases currently undergoing treatment (multiple answers) | |||||
| Malignant tumour with anticancer drugs | 592 (0.48) | 9 (0.79) | 12 (0.56) | ≤5 (≤1.02) | 18 (0.64) |
| Malignant tumour without anticancer drugs | 1144 (0.92) | 14 (1.22) | 26 (1.21) | 9 (1.84) | 31 (1.11) |
| Cardiovascular diseases | 2211 (1.78) | 32 (2.79) | 75 (3.50) | 21 (4.29) | 86 (3.07) |
| Kidney diseases | 927 (0.75) | 11 (0.96) | 30 (1.40) | 7 (1.43) | 34 (1.21) |
| Diabetes mellitus | 4275 (3.44) | 46 (4.01) | 121 (5.64) | 36 (7.36) | 131 (4.68) |
| On dialysis treatment | 127 (0.10) | 5 (0.44) | 7 (0.33) | ≤5 (≤1.02) | 8 (0.29) |
| Chronic obstructive pulmonary disease | 405 (0.33) | 13 (1.13) | 43 (2.00) | 10 (2.04) | 46 (1.64) |
| Treatment with immunosuppressant | 1252 (1.01) | 18 (1.57) | 47 (2.19) | 12 (2.45) | 53 (1.89) |
| Preventive measures (multiple answers) | |||||
| Washing hands in running water | 76 267 (61.35) | 659 (57.50) | 1262 (58.83) | 270 (55.21) | 1651 (58.92) |
| Washing hands with soap and water | 107 309 (86.32) | 929 (81.06) | 1714 (79.91) | 374 (76.48) | 2269 (80.98) |
| Hand disinfection with alcohol | 88 239 (70.98) | 702 (61.26) | 1349 (62.89) | 267 (54.60) | 1784 (63.67) |
| Etiquette (masks, handkerchiefs and so on) in case of coughing or sneezing | 108 158 (87.00) | 940 (82.02) | 1789 (83.4) | 374 (76.48) | 2355 (84.05) |
| Take time off from school or work when you have a fever or other symptoms | 48 852 (39.3) | 546 (47.64) | 779 (36.32) | 213 (43.56) | 1112 (39.69) |
| Gargling with water | 62 420 (50.21) | 481 (41.97) | 897 (41.82) | 172 (35.17) | 1206 (43.04) |
| Gargling with iodine | 14 285 (11.49) | 148 (12.91) | 273 (12.73) | 73 (14.93) | 348 (12.42) |
| Regular ventilation | 68 717 (55.27) | 518 (45.20) | 935 (43.59) | 206 (42.13) | 1247 (44.50) |
| Maintaining humidity | 26 893 (21.63) | 205 (17.89) | 392 (18.28) | 94 (19.22) | 503 (17.95) |
| A well-balanced diet | 54 256 (43.64) | 356 (31.06) | 589 (27.46) | 138 (28.22) | 807 (28.80) |
| Regular exercise | 29 453 (23.69) | 170 (14.83) | 260 (12.12) | 67 (13.70) | 363 (12.96) |
| Getting plenty of rest | 56 491 (45.44) | 399 (34.82) | 721 (33.61) | 156 (31.90) | 964 (34.40) |
| Telework | 5578 (4.49) | 40 (3.49) | 73 (3.40) | 18 (3.68) | 95 (3.39) |
| Staggered commuting | 3260 (2.62) | 23 (2.01) | 48 (2.24) | 10 (2.04) | 61 (2.18) |
| Avoidance of crowds other than staggered commuting | 23 597 (18.98) | 148 (12.91) | 279 (13.01) | 46 (9.41) | 381 (13.6) |
| Staying up-to-date on COVID-19 | 73 806 (59.37) | 505 (44.07) | 1078 (50.26) | 199 (40.7) | 1384 (49.39) |
| Other preventive measures | 1657 (1.33) | 13 (1.13) | 40 (1.86) | 9 (1.84) | 44 (1.57) |
| No preventive measures | 774 (0.62) | 23 (2.01) | 39 (1.82) | 16 (3.27) | 46 (1.64) |
*For the purpose of anonymisation, if there was one item with fewer than five people in each variable, it was combined with the numbers in the item above. If there were more than one item with less than five people, each is indicated as ‘less than five people’.
Figure 2Maps of the number of non-specific symptoms in five prefectures. The black line represents the road network. The blocks are divided by municipality. The thin black line indicates boundaries. Within the green box, three subregions in Kagawa Prefecture are plotted by postcode level. Panels: (A) condition A (fever); (B) condition B (strong feeling of weariness or shortness of breath); (C) both conditions A and B; and (D) either condition A or B. The grey areas indicate there were no participants.
Figure 3Maps plotting the age-sex-standardised incidence rate of the risk of non-specific symptoms in five prefectures. The black line represents the road network. The blocks are divided by municipality. The white line indicates boundaries. Within the green box, three subregions in Kagawa Prefecture are plotted by postcode level. Panels: (A) condition A (fever); (B) condition B (strong feeling of weariness or shortness of breath); (C) both conditions A and B; and (D) either condition A or B. The grey areas indicate there were no participants.
Figure 4Maps plotting the age-sex-standardised incidence rate (EBSIR) of having condition A at the postcode level in Kagawa Prefecture before (top) and after (middle) the declaration of state of emergency, and (bottom) the mean and SD of EBSIR by distance from the Kagawa prefectural office. The grey areas indicate there were no participants.